On this page
FA2H
fatty acid 2-hydroxylase
The <i>FA2H</i> gene encodes fatty acid 2-hydroxylase, an enzyme crucial for modifying fatty acids that contribute to the formation of myelin, the protective sheath around nerve cells. The <i>FA2H</i> gene provides instructions for synthesising an enzyme called fatty acid 2-hydroxylase.
FA2H is located on the long (q) arm of chromosome 16, at band 16q23.1. Arm ratio per GRCh38 - banding schematic.
Explore chromosome 16 in the library →Available at Jeen Health
Clinical tests that include this
Overview
The <i>FA2H</i> gene, or fatty acid 2-hydroxylase, is fundamental for producing an enzyme involved in lipid metabolism. This enzyme is particularly important for the synthesis of 2-hydroxylated fatty acids, which are critical building blocks for myelin.
Disruptions in the function of the <i>FA2H</i> gene can impact the nervous system, leading to conditions that affect movement and neurological function. The gene's role in maintaining healthy myelin suggests its importance in overall neurological health.
What the gene does
The <i>FA2H</i> gene directs the production of fatty acid 2-hydroxylase, an enzyme responsible for a specific modification of fatty acids. This enzyme adds a single oxygen atom to a hydrogen atom at a particular position on a fatty acid, yielding a 2-hydroxylated fatty acid. These modified fatty acids are integral to the structure and stability of myelin.
Myelin forms the protective covering that insulates nerve fibres in the brain and spinal cord, collectively known as white matter. Proper myelination is essential for the efficient and rapid transmission of electrical signals along nerves. When <i>FA2H</i> function is impaired, the formation of normal myelin can be disrupted, affecting neurological processes.
Video: Genetics 101
Chromosome location
The <i>FA2H</i> gene is located on chromosome 16, specifically at position 16q23.1. This genomic location is where the gene resides within the human genome, providing the cellular machinery with the instructions to produce the fatty acid 2-hydroxylase enzyme.
Protein structure
The FA2H protein consists of 372 amino acids. It features two main functional domains: the Cytochrome b5 heme-binding domain, located between amino acids 8 and 86, and the Fatty acid hydroxylase domain, found between amino acids 219 and 361. These domains are critical for the enzyme's ability to bind to haem and catalyse the hydroxylation of fatty acids.
Key variants
Variations within the <i>FA2H</i> gene can affect the enzyme's ability to modify fatty acids, potentially leading to neurological dysfunction. These genetic changes can range from single base pair substitutions to larger alterations, each with varying impacts on protein function. The clinical significance of any specific variant is assessed through detailed genetic analysis.
Sample of pathogenic variants
10 pathogenic / likely-pathogenic variants from ClinVar, ranked by review status (expert-panel-reviewed first). This is a sample; recurrent founder variants in a specific population may not appear here - see the full ClinVar listing via the link above.
| Variant (HGVS) | Protein change | Classification | Evidence | Associated condition |
|---|---|---|---|---|
c.363+2T>C | - | Pathogenic/Likely pathogenic | ★★☆☆ | Hereditary spastic paraplegia 35 |
c.379C>T | p.Arg127Ter | Pathogenic/Likely pathogenic | ★★☆☆ | Hereditary spastic paraplegia 35 |
c.506+1G>C | - | Pathogenic/Likely pathogenic | ★★☆☆ | Spastic paraplegia |
c.589C>T | p.Arg197Ter | Pathogenic/Likely pathogenic | ★★☆☆ | Hereditary spastic paraplegia 35 |
c.704G>A | p.Arg235His | Pathogenic/Likely pathogenic | ★★☆☆ | Hereditary spastic paraplegia 35 |
c.806G>A | p.Arg269His | Pathogenic/Likely pathogenic | ★★☆☆ | Spastic paraplegia |
c.822del | p.Val275fs | Pathogenic/Likely pathogenic | ★★☆☆ | Hereditary spastic paraplegia 35 |
c.888del | p.Gly298fs | Pathogenic | ★★☆☆ | Spastic paraplegia |
c.911dup | p.Leu305fs | Pathogenic | ★★☆☆ | Hereditary spastic paraplegia 35 |
c.941_945del | p.Thr314fs | Pathogenic/Likely pathogenic | ★★☆☆ | Spastic paraplegia |
Evidence stars indicate ClinVar review status. Individual variant interpretation should always be performed by a qualified clinical laboratory - many variants remain classified as Variants of Uncertain Significance (VUS) pending more research.
Associated conditions
Pathogenic variants in the <i>FA2H</i> gene are associated with several neurological conditions, most notably Spastic paraplegia type 35 (AR), also known as fatty acid hydroxylase-associated neurodegeneration (FAHN). This progressive disorder typically manifests in childhood or adolescence, affecting movement and vision. Brain imaging in affected individuals often reveals abnormal iron accumulation, particularly in certain regions of the brain.
- Spastic paraplegia type 35 Dedicated page coming soon
UK clinical status
In the UK, the <i>FA2H</i> gene is included in several NHS Genomic Medicine Service 'green' panels, indicating that there is strong evidence for its association with specific conditions. These panels include 'Ataxia and cerebellar anomalies - childhood onset', 'Dystonia, chorea or related movement disorder, childhood onset', 'Early onset dystonia', 'Hereditary neuropathy or pain disorder', 'Hereditary spastic paraplegia', 'Hereditary spastic paraplegia, adult onset', 'Hereditary spastic paraplegia, childhood onset (R61)', 'Likely inborn error of metabolism (R98)', 'Structural basal ganglia disorders', and 'White matter disorders and cerebral calcification - childhood onset'.
Sources: NHS GMS PanelApp · Genomics England PanelApp · NHS National Genomic Test Directory
Frequently asked questions
What is the primary function of the <i>FA2H</i> gene?
The <i>FA2H</i> gene provides instructions for the fatty acid 2-hydroxylase enzyme, which modifies fatty acids by adding an oxygen atom. These modified fatty acids are crucial components for forming myelin, the protective sheath around nerve cells.
What health conditions are associated with the <i>FA2H</i> gene?
Variants in the <i>FA2H</i> gene are primarily linked to Spastic paraplegia type 35, also known as fatty acid hydroxylase-associated neurodegeneration (FAHN). This is a progressive neurological disorder affecting movement and vision.
How does <i>FA2H</i> affect the nervous system?
The enzyme produced by <i>FA2H</i> is essential for creating specific 2-hydroxylated fatty acids needed for normal myelin development. Myelin insulates nerves for rapid signal transmission, so impaired <i>FA2H</i> function can disrupt this process and lead to neurological issues.
References
- Gregory A, Hayflick SJ. Genetics of neurodegeneration with brain iron accumulation. Current neurology and neuroscience reports. 2011. PMID: 21286947
- Dick KJ, Eckhardt M, Paisán-Ruiz C. Mutation of FA2H underlies a complicated form of hereditary spastic paraplegia (SPG35). Human mutation. 2010. PMID: 20104589
- Kruer MC, Paisán-Ruiz C, Boddaert N. Defective FA2H leads to a novel form of neurodegeneration with brain iron accumulation (NBIA). Annals of neurology. 2010. PMID: 20853438
- Schneider SA, Bhatia KP. Three faces of the same gene: FA2H links neurodegeneration with brain iron accumulation, leukodystrophies, and hereditary spastic paraplegias. Annals of neurology. 2010. PMID: 21031573
- Edvardson S, Hama H, Shaag A. Mutations in the fatty acid 2-hydroxylase gene are associated with leukodystrophy with spastic paraparesis and dystonia. American journal of human genetics. 2008. PMID: 19068277
- Alderson NL, Rembiesa BM, Walla MD. The human FA2H gene encodes a fatty acid 2-hydroxylase. The Journal of biological chemistry. 2004. PMID: 15337768
- Adam MP, Bick S, Mirzaa GM. Fatty Acid Hydroxylase-Associated Neurodegeneration. 1993. PMID: 21735565